These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26271141)

  • 1. Effect of golimumab and pamidronate on clinical efficacy and MRI inflammation in axial spondyloarthritis: a 48-week open randomized trial.
    Mok CC; Li OC; Chan KL; Ho LY; Hui PK
    Scand J Rheumatol; 2015; 44(6):480-6. PubMed ID: 26271141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis.
    Sieper J; van der Heijde D; Dougados M; Maksymowych WP; Scott BB; Boice JA; Berd Y; Bergman G; Curtis S; Tzontcheva A; Huyck S; Weng HH
    Arthritis Rheumatol; 2015 Oct; 67(10):2702-12. PubMed ID: 26139307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.
    Dougados M; van der Heijde D; Sieper J; Braun J; Citera G; Lenaerts J; van den Bosch F; Wei JC; Pedersen R; Bonin R; Jones H; Marshall L; Logeart I; Vlahos B; Bukowski JF; Maksymowych WP
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1590-1598. PubMed ID: 28482137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
    Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
    Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints.
    Varkas G; Jans L; Cypers H; Van Praet L; Carron P; Elewaut D; Van den Bosch F
    Arthritis Rheumatol; 2016 Mar; 68(3):672-8. PubMed ID: 26473982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial.
    van der Heijde D; Sieper J; Maksymowych WP; Lambert RG; Chen S; Hojnik M; Anderson JK; Pangan AL
    Arthritis Res Ther; 2018 Mar; 20(1):61. PubMed ID: 29587851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.
    Navarro-Compán V; Ramiro S; Landewé R; Dougados M; Miceli-Richard C; Richette P; van der Heijde D
    Ann Rheum Dis; 2016 May; 75(5):874-8. PubMed ID: 26403689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
    Maksymowych WP; Jhangri GS; Fitzgerald AA; LeClercq S; Chiu P; Yan A; Skeith KJ; Aaron SL; Homik J; Davis P; Sholter D; Russell AS
    Arthritis Rheum; 2002 Mar; 46(3):766-73. PubMed ID: 11920413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local infliximab injection of sacroiliac joints in non-radiographic axial spondyloarthritis: Impact on clinical and magnetic resonance imaging parameters of disease activity.
    Soliman E; El-Tantawi G; Matrawy K; Aldawoudy A; Naguib A
    Mod Rheumatol; 2015 May; 25(3):421-6. PubMed ID: 25401227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.
    Lambert RG; Salonen D; Rahman P; Inman RD; Wong RL; Einstein SG; Thomson GT; Beaulieu A; Choquette D; Maksymowych WP
    Arthritis Rheum; 2007 Dec; 56(12):4005-14. PubMed ID: 18050198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis.
    van der Heijde D; Sieper J; Maksymowych WP; Brown MA; Lambert RG; Rathmann SS; Pangan AL
    Arthritis Rheumatol; 2014 Mar; 66(3):667-73. PubMed ID: 24574227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.
    Zhang Y; Guo Z; Zhan Y; Qu J; Lei X
    BMC Musculoskelet Disord; 2022 Jul; 23(1):654. PubMed ID: 35804360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
    Sieper J; van der Heijde D; Dougados M; Mease PJ; Maksymowych WP; Brown MA; Arora V; Pangan AL
    Ann Rheum Dis; 2013 Jun; 72(6):815-22. PubMed ID: 22772328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial.
    Li Q; Li L; Bi L; Xiao C; Lin Z; Cao S; Liao Z; Gu J
    Trials; 2016 Jul; 17(1):337. PubMed ID: 27449221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in MRI in patients with spondyloarthritis treated with anti-TNF agents: systematic review of the literature and meta-analysis.
    Khoury G; Combe B; Morel J; Lukas C
    Clin Exp Rheumatol; 2021; 39(2):242-252. PubMed ID: 33506749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index.
    Maksymowych WP; Mallon C; Morrow S; Shojania K; Olszynski WP; Wong RL; Sampalis J; Conner-Spady B
    Ann Rheum Dis; 2009 Jun; 68(6):948-53. PubMed ID: 18524792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study.
    Deodhar A; Shiff NJ; Gong C; Chan EKH; Hsia EC; Lo KH; Akawung A; Kim L; Xu S; Reveille JD
    Rheumatol Ther; 2023 Aug; 10(4):983-999. PubMed ID: 37322274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index in Turkish patients with ankylosing spondylitis: relationship with disease activity and quality of life.
    Zahiroglu Y; Ulus Y; Akyol Y; Tander B; Durmus D; Bilgici A; Kuru O
    Int J Rheum Dis; 2014 Feb; 17(2):173-80. PubMed ID: 24576273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.